| The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis … C Roubille, V Richer, T Starnino, C McCourt, A McFarlane, P Fleming, ... Annals of the rheumatic diseases 74 (3), 480-489, 2015 | 966 | 2015 |
| Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo‐controlled trial S Carette, H Moffet, J Tardif, L Bessette, F Morin, P Frémont, V Bykerk, ... Arthritis & rheumatism 48 (3), 829-838, 2003 | 582 | 2003 |
| Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT … GR Burmester, JM Kremer, F Van den Bosch, A Kivitz, L Bessette, Y Li, ... The Lancet 391 (10139), 2503-2512, 2018 | 434 | 2018 |
| Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double‐blind, randomized … R Fleischmann, AL Pangan, IH Song, E Mysler, L Bessette, C Peterfy, ... Arthritis & rheumatology 71 (11), 1788-1800, 2019 | 406 | 2019 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 375 | 2018 |
| Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a … LM Wildi, JP Raynauld, J Martel-Pelletier, A Beaulieu, L Bessette, F Morin, ... Annals of the rheumatic diseases 70 (6), 982-989, 2011 | 331 | 2011 |
| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 306 | 2019 |
| The care gap in diagnosis and treatment of women with a fragility fracture L Bessette, LG Ste-Marie, S Jean, KS Davison, M Beaulieu, M Baranci, ... Osteoporosis International 19, 79-86, 2008 | 233 | 2008 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 228 | 2020 |
| Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme SB Cohen, RF Van Vollenhoven, KL Winthrop, CAF Zerbini, Y Tanaka, ... Annals of the rheumatic diseases 80 (3), 304-311, 2021 | 218 | 2021 |
| Predictors of outcomes of carpal tunnel release JN Katz, E Losina, BC Amick III, AH Fossel, L Bessette, RB Keller Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 210 | 2001 |
| Maine Carpal Tunnel Study: outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort JN Katz, RB Keller, BP Simmons, WD Rogers, L Bessette, AH Fossel, ... The Journal of hand surgery 23 (4), 697-710, 1998 | 207 | 1998 |
| The burden of illness of osteoporosis in Canada JE Tarride, RB Hopkins, WD Leslie, S Morin, JD Adachi, A Papaioannou, ... Osteoporosis International 23, 2591-2600, 2012 | 201 | 2012 |
| Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome L Bessette, O Sangha, KM Kuntz, RB Keller, RA Lew, AH Fossel, JN Katz Medical care 36 (4), 491-502, 1998 | 189 | 1998 |
| Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with … RM Fleischmann, MC Genovese, JV Enejosa, E Mysler, L Bessette, ... Annals of the rheumatic diseases 78 (11), 1454-1462, 2019 | 163 | 2019 |
| Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian Dermatology … C Roubille, V Richer, T Starnino, C McCourt, A McFarlane, P Fleming, ... The Journal of rheumatology 42 (10), 1767-1780, 2015 | 162 | 2015 |
| The current economic burden of illness of osteoporosis in Canada RB Hopkins, N Burke, C Von Keyserlingk, WD Leslie, SN Morin, ... Osteoporosis International 27, 3023-3032, 2016 | 147 | 2016 |
| Prevalence and predictors of long‐term work disability due to carpal tunnel syndrome JN Katz, RA Lew, L Bessette, L Punnett, AH Fossel, N Mooney, RB Keller American journal of industrial medicine 33 (6), 543-550, 1998 | 145 | 1998 |
| Predictors of return to work following carpal tunnel release JN Katz, RB Keller, AH Fossel, L Punnett, L Bessette, BP Simmons, ... American Journal of Industrial Medicine 31 (1), 85-91, 1997 | 138 | 1997 |
| Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review P Fleming, C Roubille, V Richer, T Starnino, C McCourt, A McFarlane, ... Journal of the European Academy of Dermatology and Venereology 29 (6), 1063-1070, 2015 | 121 | 2015 |
